Neuropsychiatric disorders in Parkinson's disease

被引:8
|
作者
Noé-Sebastián, E [1 ]
Irimia-Sieira, P [1 ]
Pomares-Arias, E [1 ]
Martínez-Vila, E [1 ]
Luquin-Piudo, MR [1 ]
机构
[1] Univ Navarra Clin, Fac Med, Dept Neurol, E-31008 Pamplona, Spain
关键词
neuropsychiatric disorders; Parkinson's disease;
D O I
10.33588/rn.3207.2000179
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective. This paper reviews the main neuropsychiatric disorders associated, with Parkinson's disease (PD) and describes the neuropathological hypothesis proposed to explain these symptoms. Development. This disease is usually associated with neuropsychiatric complications such as depression, anxiety and apathy. Besides, psychiatric symptoms are one of the most common side effects of antiparkinsonian drug-therapy. Conclusions. Depression is the most frequent emotional disorder reported inpatients with PD. Up to 20% of parkinsonian patients meet DSM-IV criteria for major depressive episode and another 20% for dysthymia, while the prevalence of depression in normal aged population is about 2-8%. The relationship between PD and depression has not been fully established Some investigators have suggested that depressive symptoms in PD are causally related to the underlying neuropathological process, affecting predominantly serotoninergic and dopaminergic pathways. Alternatively, depression in PD may represent a normal reaction to the progressive physical impairment induced by the disease. Otherwise, up to 20% of parkinsonian patients present levodopa-induced psychiatric complications. Visual hallucinations are the commonest, but delusions, confusional states, sexual disorders and sleep disorders have also been described Serotonine and dopamine have been implicated in the neuropathological basis of these disorders.
引用
收藏
页码:676 / 681
页数:6
相关论文
共 50 条
  • [41] The epigenetics of neuropsychiatric symptoms in Parkinson's disease
    Moore, K.
    O'Neill, F. A.
    Johnston, J. A.
    Passmore, P.
    Ross, O. A.
    Lynch, T.
    Roberts, K.
    Craig, D.
    MOVEMENT DISORDERS, 2011, 26 : S108 - S109
  • [42] Neuropsychiatric effects of Parkinson's disease treatment
    Aarons, Sallyanne
    Peisah, Carmelle
    Wijeratne, Chanaka
    AUSTRALASIAN JOURNAL ON AGEING, 2012, 31 (03) : 198 - 202
  • [43] Neuropsychiatric complications of Parkinson's disease.
    Marsh, L
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2002, 10 (02): : 12 - 13
  • [44] Neuropsychiatric symptoms in untreated Parkinson's disease
    Szatmari, Szabolcs
    Illigens, Ben Min-Woo
    Siepmann, Timo
    Pinter, Alexandra
    Takats, Annamaria
    Bereczki, Daniel
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 815 - 826
  • [45] Progression of neuropsychiatric symptoms in Parkinson's disease
    Dlay, J.
    Duncan, G.
    Khoo, T.
    Williams-Gray, C.
    Breen, D.
    Barker, R.
    Burn, D.
    Lawson, R.
    Yarnall, A.
    MOVEMENT DISORDERS, 2019, 34 : S150 - S150
  • [46] Neuropsychiatric aspects of Parkinson's disease.
    Aarsland D.
    Karlsen K.
    Current Psychiatry Reports, 1999, 1 (1) : 61 - 68
  • [47] Managing the neuropsychiatric symptoms of Parkinson's disease
    Lieberman, A
    NEUROLOGY, 1998, 50 (06) : S33 - S38
  • [48] Parkinson's disease and its neuropsychiatric features
    Marsh, L
    INTERNATIONAL REVIEW OF PSYCHIATRY, 2000, 12 (04) : 261 - 262
  • [49] NEUROPSYCHIATRIC ASPECTS OF DBS FOR PARKINSON'S DISEASE
    Walterfang, M.
    Marsh, R.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2022, 56 (1_SUPPL): : 129 - 129
  • [50] Screening for neuropsychiatric symptoms in Parkinson's disease
    Barrett, M. J.
    Sperling, S. A.
    Shah, B. B.
    Flanigan, J. L.
    Wooten, G. F.
    Harrison, M. B.
    Manning, C. A.
    MOVEMENT DISORDERS, 2016, 31 : S492 - S492